Abstract Library

#4520 Is late diagnosis and carcinoid heart disease (CaHD) associated with deprivation index? – An audit of practice and assessment of deprivation index in Sheffield ENETS Centre of Excellence

Introduction: Delays to diagnosis in neuroendocrine neoplasms is a world-wide problem. Challenges and inequities recognised include low awareness and access to expert centres. Indices of multiple deprivation (IMD) assess the least to the most deprived areas in the UK, 1 being the most deprived of the 10 deciles.

Conference:

Presenting Author: Munir A

Authors: Abdella O, Abdelhaleem E, Kwok W, Harber J, Rowett O,

Keywords: Index of multiple deprivation, carcinoid syndrome, carcinoid heart disease,

#3653 Neuroendocrine urological tumors – Experience of the medical oncology department of the hospital November 1st, 1954, in Oran (Algeria)

Introduction: Neuroendocrine tumors (NET) are mainly located in the digestive tract (85%) and the lung (10%). The other localizations are rare, notably at the urological tract with an uncertain prognosis. At diagnostic, these tumors are often in the metastatic stage. Their treatment is based on chemotherapy (platinum drug).

Conference:

Presenting Author:

Authors: Kehili H, Bengueddache A, Boumansour N, Kaid M, Benabdellah H,

Keywords: neuroendocrine urological tumor, poor prognosis,

#3418 Neuroendocrine tumor of the kidney: About an observation

Introduction: Renal neuroendocrine tumors are very rare, with an uncertain prognosis. It is immunostaining with chromogranin A and synaptophysin that confirms the diagnosis.

Conference:

Presenting Author:

Authors: Kehili H, Bengueddache A, Boumansour N, Kaid M, Benabdellah H,

Keywords: Renal neuroendocrine tumor, rare, bad prognosis,

#3363 Neuroendocrine prostate cancer: About 4 cases

Introduction: Neuroendocrine tumors of the prostate are rare entities with a very poor prognosis. They can be pure (small or large cell neuroendocrine carcinoma) or mixed. They do not express prostate specific antigen (PSA) or the androgen receptor. Their treatment is based only on chemotherapy based on platinum for the advanced forms.

Conference:

Presenting Author:

Authors: Kehili H, Bengueddache A, Boumansour N, Kaid M, Benabdellah H,

Keywords: neuroendocrine prostate, poor prognosis,

#2879 Lung Neuroendocrine Tumors: Experience of Medical Oncology Department of Hospital 1st November 1954 Oran

Introduction: Lung neuroendocrine tumors account for 25% of all neuroendocrine tumors. It is a heterogeneous group that meets morphological criteria; immunohistochemical and molecular; defining 4 groups: Typical and atypical carcinoid tumors, neuroendocrine carcinomas with large cell and small cells. Carcinoid syndrome is rare in these tumors and the treatment is based on surgery for localized forms and multimodal treatment for metastatic forms.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Kehili H, Bengueddach A, Kaid M, Allaoui M, Benabdellah H,

Keywords: lung neuroendocrine tumors, rare, prognosis,